 | • レポートコード：GIR-2104Z07979 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、IVIGのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。IVIGの種類別市場規模（注射、凍結乾燥粉末）、用途別市場規模（多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚・運動ニューロパシー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・IVIGの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Green Cross、BSV、Hualan Bio、RAAS、YUAN DA SHUYANG、Kangbao Bio、Tiantan Bio、Taibang Bio、Weiguang Bio、SIBP、TONROL、RUIDE Bio、BOYA Bio、RUIDE Bio、Xinxing Medicine、Weilun Bio、WIBP ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、凍結乾燥粉末 ・用途別分析2016年-2026年：多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚・運動ニューロパシー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス ・IVIGの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・IVIGのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・IVIGのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・IVIGの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・IVIGの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The IVIG market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global IVIG size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global IVIG market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
IVIG market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Lyophilized Powder
Market segment by Application can be divided into
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis
The key market players for global IVIG market are listed below:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 IVIG Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IVIG Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Lyophilized Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global IVIG Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Multiple Sclerosis (MS)
1.3.3 Myasthenia Gravis (MG)
1.3.4 Multifocal Motor Neuropathy (MMN)
1.3.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
1.3.6 Dermatomyositis
1.3.7 Polymyositis
1.4 Global IVIG Market Size & Forecast
1.4.1 Global IVIG Sales in Value (2016-2026))
1.4.2 Global IVIG Sales in Volume (2016-2026)
1.4.3 Global IVIG Price by Type (2016-2026) & (USD/Unit)
1.5 Global IVIG Production Capacity Analysis
1.5.1 Global IVIG Total Production Capacity (2016-2026)
1.5.2 Global IVIG Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IVIG Market Drivers
1.6.2 IVIG Market Restraints
1.6.3 IVIG Trends Analysis
2 Manufacturers Profiles
2.1 Green Cross
2.1.1 Green Cross Details
2.1.2 Green Cross Major Business
2.1.3 Green Cross IVIG Product and Services
2.1.4 Green Cross IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 BSV
2.2.1 BSV Details
2.2.2 BSV Major Business
2.2.3 BSV IVIG Product and Services
2.2.4 BSV IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Hualan Bio
2.3.1 Hualan Bio Details
2.3.2 Hualan Bio Major Business
2.3.3 Hualan Bio IVIG Product and Services
2.3.4 Hualan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 RAAS
2.4.1 RAAS Details
2.4.2 RAAS Major Business
2.4.3 RAAS IVIG Product and Services
2.4.4 RAAS IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 YUAN DA SHUYANG
2.5.1 YUAN DA SHUYANG Details
2.5.2 YUAN DA SHUYANG Major Business
2.5.3 YUAN DA SHUYANG IVIG Product and Services
2.5.4 YUAN DA SHUYANG IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Kangbao Bio
2.6.1 Kangbao Bio Details
2.6.2 Kangbao Bio Major Business
2.6.3 Kangbao Bio IVIG Product and Services
2.6.4 Kangbao Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Tiantan Bio
2.7.1 Tiantan Bio Details
2.7.2 Tiantan Bio Major Business
2.7.3 Tiantan Bio IVIG Product and Services
2.7.4 Tiantan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Taibang Bio
2.8.1 Taibang Bio Details
2.8.2 Taibang Bio Major Business
2.8.3 Taibang Bio IVIG Product and Services
2.8.4 Taibang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Weiguang Bio
2.9.1 Weiguang Bio Details
2.9.2 Weiguang Bio Major Business
2.9.3 Weiguang Bio IVIG Product and Services
2.9.4 Weiguang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 SIBP
2.10.1 SIBP Details
2.10.2 SIBP Major Business
2.10.3 SIBP IVIG Product and Services
2.10.4 SIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 TONROL
2.11.1 TONROL Details
2.11.2 TONROL Major Business
2.11.3 TONROL IVIG Product and Services
2.11.4 TONROL IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 RUIDE Bio
2.12.1 RUIDE Bio Details
2.12.2 RUIDE Bio Major Business
2.12.3 RUIDE Bio IVIG Product and Services
2.12.4 RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 BOYA Bio
2.13.1 BOYA Bio Details
2.13.2 BOYA Bio Major Business
2.13.3 BOYA Bio IVIG Product and Services
2.13.4 BOYA Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 RUIDE Bio
2.14.1 RUIDE Bio Details
2.14.2 RUIDE Bio Major Business
2.14.3 RUIDE Bio IVIG Product and Services
2.14.4 RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Xinxing Medicine
2.15.1 Xinxing Medicine Details
2.15.2 Xinxing Medicine Major Business
2.15.3 Xinxing Medicine IVIG Product and Services
2.15.4 Xinxing Medicine IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Weilun Bio
2.16.1 Weilun Bio Details
2.16.2 Weilun Bio Major Business
2.16.3 Weilun Bio IVIG Product and Services
2.16.4 Weilun Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 WIBP
2.17.1 WIBP Details
2.17.2 WIBP Major Business
2.17.3 WIBP IVIG Product and Services
2.17.4 WIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 IVIG Sales by Manufacturer
3.1 Global IVIG Sales in Volume by Manufacturer (2019-2021e)
3.2 Global IVIG Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in IVIG
3.4 Market Concentration Rate
3.4.1 Top 3 IVIG Manufacturer Market Share
3.4.2 Top 6 IVIG Manufacturer Market Share
3.5 Global IVIG Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and IVIG Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global IVIG Market Size by Region
4.1.1 Global IVIG Sales in Volume by Region (2016-2026)
4.1.2 Global IVIG Revenue by Region (2016-2026)
4.2 North America IVIG Revenue (2016-2026)
4.3 Europe IVIG Revenue (2016-2026)
4.4 Asia-Pacific IVIG Revenue (2016-2026)
4.5 South America IVIG Revenue (2016-2026)
4.6 Middle East and Africa IVIG Revenue (2016-2026)
5 Market Segment by Type
5.1 Global IVIG Sales in Volume by Type (2016-2026)
5.2 Global IVIG Revenue by Type (2016-2026)
5.3 Global IVIG Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global IVIG Sales in Volume by Application (2016-2026)
6.2 Global IVIG Revenue by Application (2016-2026)
6.3 Global IVIG Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America IVIG Sales by Type (2016-2026)
7.2 North America IVIG Sales by Application (2016-2026)
7.3 North America IVIG Market Size by Country
7.3.1 North America IVIG Sales in Volume by Country (2016-2026)
7.3.2 North America IVIG Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe IVIG Sales by Type (2016-2026)
8.2 Europe IVIG Sales by Application (2016-2026)
8.3 Europe IVIG Market Size by Country
8.3.1 Europe IVIG Sales in Volume by Country (2016-2026)
8.3.2 Europe IVIG Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific IVIG Sales by Type (2016-2026)
9.2 Asia-Pacific IVIG Sales by Application (2016-2026)
9.3 Asia-Pacific IVIG Market Size by Region
9.3.1 Asia-Pacific IVIG Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific IVIG Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America IVIG Sales by Type (2016-2026)
10.2 South America IVIG Sales by Application (2016-2026)
10.3 South America IVIG Market Size by Country
10.3.1 South America IVIG Sales in Volume by Country (2016-2026)
10.3.2 South America IVIG Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa IVIG Sales by Type (2016-2026)
11.2 Middle East & Africa IVIG Sales by Application (2016-2026)
11.3 Middle East & Africa IVIG Market Size by Country
11.3.1 Middle East & Africa IVIG Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa IVIG Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 IVIG Typical Distributors
12.3 IVIG Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global IVIG Revenue by Type, (USD Million), 2021-2026
Table 2. Global IVIG Revenue by Application, (USD Million), 2021-2026
Table 3. Green Cross Basic Information, Manufacturing Base and Competitors
Table 4. Green Cross Major Business
Table 5. Green Cross IVIG Product and Services
Table 6. Green Cross IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BSV Basic Information, Manufacturing Base and Competitors
Table 8. BSV Major Business
Table 9. BSV IVIG Product and Services
Table 10. BSV IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 12. Hualan Bio Major Business
Table 13. Hualan Bio IVIG Product and Services
Table 14. Hualan Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. RAAS Basic Information, Manufacturing Base and Competitors
Table 16. RAAS Major Business
Table 17. RAAS IVIG Product and Services
Table 18. RAAS IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. YUAN DA SHUYANG Basic Information, Manufacturing Base and Competitors
Table 20. YUAN DA SHUYANG Major Business
Table 21. YUAN DA SHUYANG IVIG Product and Services
Table 22. YUAN DA SHUYANG IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Kangbao Bio Basic Information, Manufacturing Base and Competitors
Table 24. Kangbao Bio Major Business
Table 25. Kangbao Bio IVIG Product and Services
Table 26. Kangbao Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 28. Tiantan Bio Major Business
Table 29. Tiantan Bio IVIG Product and Services
Table 30. Tiantan Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Taibang Bio Basic Information, Manufacturing Base and Competitors
Table 32. Taibang Bio Major Business
Table 33. Taibang Bio IVIG Product and Services
Table 34. Taibang Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 36. Weiguang Bio Major Business
Table 37. Weiguang Bio IVIG Product and Services
Table 38. Weiguang Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. SIBP Basic Information, Manufacturing Base and Competitors
Table 40. SIBP Major Business
Table 41. SIBP IVIG Product and Services
Table 42. SIBP IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. TONROL Basic Information, Manufacturing Base and Competitors
Table 44. TONROL Major Business
Table 45. TONROL IVIG Product and Services
Table 46. TONROL IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. RUIDE Bio Basic Information, Manufacturing Base and Competitors
Table 48. RUIDE Bio Major Business
Table 49. RUIDE Bio IVIG Product and Services
Table 50. RUIDE Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. BOYA Bio Basic Information, Manufacturing Base and Competitors
Table 52. BOYA Bio Major Business
Table 53. BOYA Bio IVIG Product and Services
Table 54. BOYA Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. RUIDE Bio Basic Information, Manufacturing Base and Competitors
Table 56. RUIDE Bio Major Business
Table 57. RUIDE Bio IVIG Product and Services
Table 58. RUIDE Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 60. Xinxing Medicine Major Business
Table 61. Xinxing Medicine IVIG Product and Services
Table 62. Xinxing Medicine IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Weilun Bio Basic Information, Manufacturing Base and Competitors
Table 64. Weilun Bio Major Business
Table 65. Weilun Bio IVIG Product and Services
Table 66. Weilun Bio IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. WIBP Basic Information, Manufacturing Base and Competitors
Table 68. WIBP Major Business
Table 69. WIBP IVIG Product and Services
Table 70. WIBP IVIG Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global IVIG Sales by Manufacturer (2019-2021e) & (K Units)
Table 72. Global IVIG Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in IVIG, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global IVIG Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and IVIG Production Site of Key Manufacturer
Table 76. Global IVIG Sales by Region (2016-2021e) & (K Units)
Table 77. Global IVIG Sales by Region (2021-2026) & (K Units)
Table 78. Global IVIG Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global IVIG Revenue by Region (2021-2026) & (USD Million)
Table 80. Global IVIG Sales by Type (2016-2021e) & (K Units)
Table 81. Global IVIG Sales by Type (2021-2026) & (K Units)
Table 82. Global IVIG Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global IVIG Revenue by Type (2021-2026) & (USD Million)
Table 84. Global IVIG Price by Type (2016-2021e) & (USD/Unit)
Table 85. Global IVIG Price by Type (2021-2026) & (USD/Unit)
Table 86. Global IVIG Sales by Application (2016-2021e) & (K Units)
Table 87. Global IVIG Sales by Application (2021-2026) & (K Units)
Table 88. Global IVIG Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global IVIG Revenue by Application (2021-2026) & (USD Million)
Table 90. Global IVIG Price by Application (2016-2021e) & (USD/Unit)
Table 91. Global IVIG Price by Application (2021-2026) & (USD/Unit)
Table 92. North America IVIG Sales by Country (2016-2021e) & (K Units)
Table 93. North America IVIG Sales by Country (2021-2026) & (K Units)
Table 94. North America IVIG Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America IVIG Revenue by Country (2021-2026) & (USD Million)
Table 96. North America IVIG Sales by Type (2016-2021e) & (K Units)
Table 97. North America IVIG Sales by Type (2021-2026) & (K Units)
Table 98. North America IVIG Sales by Application (2016-2021e) & (K Units)
Table 99. North America IVIG Sales by Application (2021-2026) & (K Units)
Table 100. Europe IVIG Sales by Country (2016-2021e) & (K Units)
Table 101. Europe IVIG Sales by Country (2021-2026) & (K Units)
Table 102. Europe IVIG Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe IVIG Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe IVIG Sales by Type (2016-2021e) & (K Units)
Table 105. Europe IVIG Sales by Type (2021-2026) & (K Units)
Table 106. Europe IVIG Sales by Application (2016-2021e) & (K Units)
Table 107. Europe IVIG Sales by Application (2021-2026) & (K Units)
Table 108. Asia-Pacific IVIG Sales by Region (2016-2021e) & (K Units)
Table 109. Asia-Pacific IVIG Sales by Region (2021-2026) & (K Units)
Table 110. Asia-Pacific IVIG Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific IVIG Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific IVIG Sales by Type (2016-2021e) & (K Units)
Table 113. Asia-Pacific IVIG Sales by Type (2021-2026) & (K Units)
Table 114. Asia-Pacific IVIG Sales by Application (2016-2021e) & (K Units)
Table 115. Asia-Pacific IVIG Sales by Application (2021-2026) & (K Units)
Table 116. South America IVIG Sales by Country (2016-2021e) & (K Units)
Table 117. South America IVIG Sales by Country (2021-2026) & (K Units)
Table 118. South America IVIG Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America IVIG Revenue by Country (2021-2026) & (USD Million)
Table 120. South America IVIG Sales by Type (2016-2021e) & (K Units)
Table 121. South America IVIG Sales by Type (2021-2026) & (K Units)
Table 122. South America IVIG Sales by Application (2016-2021e) & (K Units)
Table 123. South America IVIG Sales by Application (2021-2026) & (K Units)
Table 124. Middle East & Africa IVIG Sales by Country (2016-2021e) & (K Units)
Table 125. Middle East & Africa IVIG Sales by Country (2021-2026) & (K Units)
Table 126. Middle East & Africa IVIG Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa IVIG Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa IVIG Sales by Type (2016-2021e) & (K Units)
Table 129. Middle East & Africa IVIG Sales by Type (2021-2026) & (K Units)
Table 130. Middle East & Africa IVIG Sales by Application (2016-2021e) & (K Units)
Table 131. Middle East & Africa IVIG Sales by Application (2021-2026) & (K Units)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. IVIG Typical Distributors
Table 135. IVIG Typical Customers
List of Figures
Figure 1. IVIG Picture
Figure 2. Global IVIG Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Lyophilized Powder
Figure 5. Global IVIG Sales Market Share by Application in 2020
Figure 6. Multiple Sclerosis (MS)
Figure 7. Myasthenia Gravis (MG)
Figure 8. Multifocal Motor Neuropathy (MMN)
Figure 9. Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Figure 10. Dermatomyositis
Figure 11. Polymyositis
Figure 12. Global IVIG Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global IVIG Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey IVIG Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global IVIG Sales (2016-2026) & (K Units)
Figure 34. Global IVIG Production Capacity (2016-2026) & (K Units)
Figure 35. Global IVIG Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. IVIG Market Drivers
Figure 37. IVIG Market Restraints
Figure 38. IVIG Market Trends
Figure 39. Global IVIG Sales Market Share by Manufacturer in 2020
Figure 40. Global IVIG Revenue Market Share by Manufacturer in 2020
Figure 41. IVIG Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 IVIG Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 IVIG Manufacturer (Revenue) Market Share in 2020
Figure 44. Global IVIG Sales Market Share by Region (2016-2026)
Figure 45. Global IVIG Revenue Market Share by Region (2016-2026)
Figure 46. North America IVIG Revenue (2016-2026) & (USD Million)
Figure 47. Europe IVIG Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific IVIG Revenue (2016-2026) & (USD Million)
Figure 49. South America IVIG Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa IVIG Revenue (2016-2026) & (USD Million)
Figure 51. Global IVIG Sales Market Share by Type (2016-2026)
Figure 52. Global IVIG Revenue Market Share by Type (2016-2026)
Figure 53. Global IVIG Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global IVIG Sales Market Share by Application (2016-2026)
Figure 55. Global IVIG Revenue Market Share by Application (2016-2026)
Figure 56. Global IVIG Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America IVIG Sales Market Share by Country (2016-2026)
Figure 58. North America IVIG Revenue Market Share by Country (2016-2026)
Figure 59. North America IVIG Sales Market Share by Type (2016-2026)
Figure 60. North America IVIG Sales Market Share by Application (2016-2026)
Figure 61. Europe IVIG Sales Market Share by Country (2016-2026)
Figure 62. Europe IVIG Revenue Market Share by Country (2016-2026)
Figure 63. Europe IVIG Sales Market Share by Type (2016-2026)
Figure 64. Europe IVIG Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific IVIG Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific IVIG Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific IVIG Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific IVIG Sales Market Share by Application (2016-2026)
Figure 69. South America IVIG Sales Market Share by Country (2016-2026)
Figure 70. South America IVIG Revenue Market Share by Country (2016-2026)
Figure 71. South America IVIG Sales Market Share by Type (2016-2026)
Figure 72. South America IVIG Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa IVIG Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa IVIG Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa IVIG Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa IVIG Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の進行性多巣性白質脳症治療市場規模・現状・予測（2021年-2027年） Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems. Growing prevalence of HIV is expected to drive the growth of the progressiv…- 世界の重症筋無力症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Myasthenia Gravis Market The global Myasthenia Gravis market size is projected to reach US$ 2212 million by 2026, from US$ 1098.4 million in 2019, at a CAGR of 10.4% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年） Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage. Although there is no cure for diabe…
- 世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年） Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage. Although there is no cure for diabe…
- 世界の重症筋無力症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Myasthenia Gravis Treatment Market The global Myasthenia Gravis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…